Q5R504
Gene name |
FAM162A (E2IG5) |
Protein name |
Protein FAM162A |
Names |
E2-induced gene 5 protein homolog |
Species |
Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) |
KEGG Pathway |
pon:100173874 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q5R504
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q5R504-F1 | Predicted | AlphaFoldDB |
No variants for Q5R504
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q5R504 | |||||
No associated diseases with Q5R504
10 regional properties for Q5R504
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | RNA polymerase sigma-70 | 319 - 332 | IPR000943-1 |
| domain | RNA polymerase sigma-70 | 343 - 351 | IPR000943-2 |
| domain | RNA polymerase sigma-70 | 467 - 479 | IPR000943-3 |
| domain | RNA polymerase sigma-70 | 488 - 514 | IPR000943-4 |
| domain | RNA polymerase sigma-70 region 3 | 374 - 449 | IPR007624 |
| domain | RNA polymerase sigma-70 region 2 | 295 - 364 | IPR007627 |
| domain | RNA polymerase sigma-70 region 4 | 463 - 516 | IPR007630 |
| domain | RNA polymerase sigma-70 region 1.2 | 226 - 259 | IPR009042 |
| domain | RNA polymerase sigma factor RpoD, C-terminal | 291 - 527 | IPR012760 |
| domain | RNA polymerase sigma-70 like domain | 291 - 516 | IPR014284 |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| mitochondrial membrane | Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
5 GO annotations of biological process
| Name | Definition |
|---|---|
| activation of cysteine-type endopeptidase activity involved in apoptotic process | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. |
| cellular response to hypoxia | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
| neuron apoptotic process | Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system. |
| positive regulation of apoptotic process | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| positive regulation of release of cytochrome c from mitochondria | Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGSLSGLRLA | AGSCFRLCER | DVFSSLRLTR | SSDLKRINGF | CTKPQESPRA | PSRTYNRVPL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| HKPTEWQKKI | LVWSGRFKKE | DEIPETVSLE | MLDTAKNKMR | VKISYLMIAL | TVVGCICMVI |
| 130 | 140 | 150 | |||
| EGKKAAQRHE | SLTSLNLEKK | ARLREEAAMK | AKTE |